<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00654290</url>
  </required_header>
  <id_info>
    <org_study_id>55318</org_study_id>
    <secondary_id>NIH of IRAN</secondary_id>
    <nct_id>NCT00654290</nct_id>
  </id_info>
  <brief_title>Effect of Prophylaxy of Amiodarone and Propranolol and Amiodarone With Propranolol in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft</brief_title>
  <official_title>Effect of Prophylaxy of Amiodarone and Propranolol and Amiodarone With Propranolol in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft, A Prospective Double-Blind Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shiraz University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shiraz University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Atrial fibrillation is the most common arrhythmia post coronary bypass surgery, currently
      B-blockers are the class I indication to prevent AF post CABG. We decide to evaluate use of
      propranolol and amiodarone separately and together to find a better prophylaxis for AF
      peri-CABG
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this double blind randomized study 240 consecutive patients underwent elective coronary
      artery bypass grafting, being randomized prospectively into three groups, propranolol (p)
      (n=80), amiodarone (A) (n=80) and amiodarone with propranolol (AP) (n=80).

      All groups received their medications from 7 days preoperatively and continued their
      medications for 5 days post CABG.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">February 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of atrial fibrillation post CABG</measure>
    <time_frame>7 days post CABG</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>bradycardia, mortality, hypotension, morbidity</measure>
    <time_frame>7 days post CABG</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">240</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>P</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Propranolol from 7 days pre-operation to 5 days post CABG</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Amiodarone treated 7 days pre-operation to 5 days post CABG</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Amiodarone and Propranolol 7 days pre-operation to 5 days post CABG</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amiodarone + Propranolol</intervention_name>
    <description>Amiodarone and Propranolol 7 days pre-operation to 5 days post CABG</description>
    <arm_group_label>AP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amiodarone</intervention_name>
    <description>Amiodarone treated 7 days pre-operation to 5 days post CABG</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propranolol</intervention_name>
    <description>Propranolol from 7 days pre-operation to 5 days post CABG</description>
    <arm_group_label>P</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient who are going to have elective CABG

          -  Signing informed consent

        Exclusion Criteria:

          -  EF&lt;35%

          -  Bradycardia&lt;60 per min

          -  Hypotension&lt; 100 mmhg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Shiraz University of Medical Sciences/Cardiac Surgery and Cardiology Ward/Namazi and Shahid Faghihi Hospital</name>
      <address>
        <city>Shiraz</city>
        <state>Fars</state>
        <zip>71345</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>April 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 2, 2008</study_first_submitted>
  <study_first_submitted_qc>April 4, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2008</study_first_posted>
  <last_update_submitted>April 4, 2008</last_update_submitted>
  <last_update_submitted_qc>April 4, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2008</last_update_posted>
  <responsible_party>
    <name_title>shiraz university of medical sciences/Dr kojuri</name_title>
    <organization>National Institute of Health</organization>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <keyword>coronary bypass</keyword>
  <keyword>Amiodarone</keyword>
  <keyword>Propranolol</keyword>
  <keyword>Coronary Artery Bypass Graft (CABG)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propranolol</mesh_term>
    <mesh_term>Amiodarone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

